Cargando…

Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells

Background: Endothelial function significantly depends on the proteolytic release of surface expressed signal molecules, their receptors and adhesion molecules via the metalloproteinase ADAM17. The pseudoproteases iRhom1 and 2 independently function as adapter proteins for ADAM17 and are essential f...

Descripción completa

Detalles Bibliográficos
Autores principales: Babendreyer, Aaron, Rojas-González, Diana M., Giese, Anja Adelina, Fellendorf, Sandra, Düsterhöft, Stefan, Mela, Petra, Ludwig, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736406/
https://www.ncbi.nlm.nih.gov/pubmed/33335915
http://dx.doi.org/10.3389/fcvm.2020.610344
_version_ 1783622785224933376
author Babendreyer, Aaron
Rojas-González, Diana M.
Giese, Anja Adelina
Fellendorf, Sandra
Düsterhöft, Stefan
Mela, Petra
Ludwig, Andreas
author_facet Babendreyer, Aaron
Rojas-González, Diana M.
Giese, Anja Adelina
Fellendorf, Sandra
Düsterhöft, Stefan
Mela, Petra
Ludwig, Andreas
author_sort Babendreyer, Aaron
collection PubMed
description Background: Endothelial function significantly depends on the proteolytic release of surface expressed signal molecules, their receptors and adhesion molecules via the metalloproteinase ADAM17. The pseudoproteases iRhom1 and 2 independently function as adapter proteins for ADAM17 and are essential for the maturation, trafficking, and activity regulation of ADAM17. Bioinformatic data confirmed that immune cells predominantly express iRhom2 while endothelial cells preferentially express iRhom1. Objective: Here, we investigate possible reasons for higher iRhom1 expression and potential inflammatory regulation of iRhom2 in endothelial cells and analyze the consequences for ADAM17 maturation and function. Methods: Primary endothelial cells were cultured in absence and presence of flow with and without inflammatory cytokines (TNFα and INFγ). Regulation of iRhoms was studied by qPCR, involved signaling pathways were studied with transcriptional inhibitors and consequences were analyzed by assessment of ADAM17 maturation, surface expression and cleavage of the ADAM17 substrate junctional adhesion molecule JAM-A. Results: Endothelial iRhom1 is profoundly upregulated by physiological shear stress. This is accompanied by a homeostatic phenotype driven by the transcription factor KLF2 which is, however, only partially responsible for regulation of iRhom1. By contrast, iRhom2 is most prominently upregulated by inflammatory cytokines. This correlates with an inflammatory phenotype driven by the transcription factors NFκB and AP-1 of which AP-1 is most relevant for iRhom2 regulation. Finally, shear stress exposure and inflammatory stimulation have independent and no synergistic effects on ADAM17 maturation, surface expression and JAM-A shedding. Conclusion: Conditions of shear stress and inflammation differentially upregulate iRhom1 and 2 in primary endothelial cells which then results in independent regulation of ADAM17.
format Online
Article
Text
id pubmed-7736406
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77364062020-12-16 Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells Babendreyer, Aaron Rojas-González, Diana M. Giese, Anja Adelina Fellendorf, Sandra Düsterhöft, Stefan Mela, Petra Ludwig, Andreas Front Cardiovasc Med Cardiovascular Medicine Background: Endothelial function significantly depends on the proteolytic release of surface expressed signal molecules, their receptors and adhesion molecules via the metalloproteinase ADAM17. The pseudoproteases iRhom1 and 2 independently function as adapter proteins for ADAM17 and are essential for the maturation, trafficking, and activity regulation of ADAM17. Bioinformatic data confirmed that immune cells predominantly express iRhom2 while endothelial cells preferentially express iRhom1. Objective: Here, we investigate possible reasons for higher iRhom1 expression and potential inflammatory regulation of iRhom2 in endothelial cells and analyze the consequences for ADAM17 maturation and function. Methods: Primary endothelial cells were cultured in absence and presence of flow with and without inflammatory cytokines (TNFα and INFγ). Regulation of iRhoms was studied by qPCR, involved signaling pathways were studied with transcriptional inhibitors and consequences were analyzed by assessment of ADAM17 maturation, surface expression and cleavage of the ADAM17 substrate junctional adhesion molecule JAM-A. Results: Endothelial iRhom1 is profoundly upregulated by physiological shear stress. This is accompanied by a homeostatic phenotype driven by the transcription factor KLF2 which is, however, only partially responsible for regulation of iRhom1. By contrast, iRhom2 is most prominently upregulated by inflammatory cytokines. This correlates with an inflammatory phenotype driven by the transcription factors NFκB and AP-1 of which AP-1 is most relevant for iRhom2 regulation. Finally, shear stress exposure and inflammatory stimulation have independent and no synergistic effects on ADAM17 maturation, surface expression and JAM-A shedding. Conclusion: Conditions of shear stress and inflammation differentially upregulate iRhom1 and 2 in primary endothelial cells which then results in independent regulation of ADAM17. Frontiers Media S.A. 2020-12-01 /pmc/articles/PMC7736406/ /pubmed/33335915 http://dx.doi.org/10.3389/fcvm.2020.610344 Text en Copyright © 2020 Babendreyer, Rojas-González, Giese, Fellendorf, Düsterhöft, Mela and Ludwig. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Babendreyer, Aaron
Rojas-González, Diana M.
Giese, Anja Adelina
Fellendorf, Sandra
Düsterhöft, Stefan
Mela, Petra
Ludwig, Andreas
Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells
title Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells
title_full Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells
title_fullStr Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells
title_full_unstemmed Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells
title_short Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells
title_sort differential induction of the adam17 regulators irhom1 and 2 in endothelial cells
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736406/
https://www.ncbi.nlm.nih.gov/pubmed/33335915
http://dx.doi.org/10.3389/fcvm.2020.610344
work_keys_str_mv AT babendreyeraaron differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells
AT rojasgonzalezdianam differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells
AT gieseanjaadelina differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells
AT fellendorfsandra differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells
AT dusterhoftstefan differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells
AT melapetra differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells
AT ludwigandreas differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells